QuantHealth: $215 Million In Financial Returns And 85% Clinical Trial Accuracy
QuantHealth, an AI-based clinical trial design company, has surpassed 100 successfully simulated trials with 85% accuracy, significantly improving ROI for pharmaceutical partners. Utilizing proprietary technology and patient-centric solutions, QuantHealth addresses trial failures, reducing study duration, trial subjects, and full-time employees, resulting in substantial financial returns. Accuracy outcomes exceeded national averages for Phase II and III, highlighting the power of AI-generated clinical trials.
Reference News
QuantHealth, an AI-based clinical trial design company, has surpassed 100 successfully simulated trials with 85% accuracy, significantly improving ROI for pharmaceutical partners. Utilizing proprietary technology and patient-centric solutions, QuantHealth addresses trial failures, reducing study duration, trial subjects, and full-time employees, resulting in substantial financial returns. Accuracy outcomes exceeded national averages for Phase II and III, highlighting the power of AI-generated clinical trials.